|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 219/06 | |
| C07C 219/08 | |||
| C07C 219/10 | |||
| C07C 229/16 | |||
| C07D 295/13 | |||
| A61K 47/50 | |||
| A61K 9/127 |
| (11) | Patento numeris | 3160938 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15730023.7 |
| Europos patento paraiškos padavimo data | 2015-06-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/034496 |
| Data | 2015-06-05 |
| (87) | Numeris | WO 2015/199952 |
| Data | 2015-12-30 |
| (30) | Numeris | Data | Šalis |
| 201462016839 P | 2014-06-25 | US |
| (72) |
ANSELL, Steven, M., CA
DU, Xinyao, CA
|
| (73) |
Acuitas Therapeutics Inc.,
6190 Agronomy Road Suite 402 University of British Columbia - KETR, Vancouver, British Columbia V6T 1W5,
CA
|
| (54) | NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS |
| NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS |